Nova Mentis Life Science (TSE:NOVA) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nova Mentis Life Science Corp. appoints Steve Loutskou as the new President and CEO, aiming to drive future growth with his extensive entrepreneurial experience. This leadership change follows the resignation of William Rascan, who significantly contributed to the company’s development, including securing an orphan drug designation for psilocybin treatment.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.